Cytek Biosciences (CTKB) Interest Coverage Ratio (2020 - 2026)
Cytek Biosciences (CTKB) posted Interest Coverage Ratio of 0.9 for Q1 2026, down 101.63% on a QoQ basis from 55.39 in Q4 2025, and down 160.63% year-over-year from 1.49 in Q1 2025.
Cytek Biosciences (CTKB) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Cytek Biosciences' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.9 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 160.63% year-over-year to 0.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.14 (down 274.51% YoY) and the FY2025 annual result came in at 1.89, changed 0.22% from the prior year.
- Interest Coverage Ratio was 0.9 for Q1 2026 at Cytek Biosciences, down from 55.39 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 55.39 in Q4 2025 and bottomed at 4.72 in Q1 2023.
- A 5-year average of 2.56 and a median of 0.44 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio tumbled 9545797.2% — and 2025, when it soared 11104.89%.
- Cytek Biosciences' Interest Coverage Ratio stood at 0.12 in 2022, then sank by 384.38% to 0.35 in 2023, then sank by 44.74% to 0.5 in 2024, then surged by 11104.89% to 55.39 in 2025, then plunged by 101.63% to 0.9 in 2026.
- Business Quant data shows CTKB's Interest Coverage Ratio at 0.9 in Q1 2026, 55.39 in Q4 2025, and 0.44 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | -0.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.90 |
| Dec 31, 2025 | 55.39 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.35 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.77 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -0.35 |
| Sep 30, 2023 | -0.50 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -4.72 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | -1.42 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 2.68 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.05 |